SCHEMBL24944172

SCHEMBL24944172

CNc1nc(Nc2ccc(CN3CCCC3)cc2)c(C(N)=O)nc1-c1cncc2c1ncn2C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TBK1 Q9UHD2 2/20 0.39
▸ IKBKE Q14164 1/20 0.39
▸ SYK P43405 2/20 0.37
▸ CCNC P24863 2/20 0.36
▸ CDK8 P49336 2/20 0.36
▸ MELK Q14680 1/20 0.36
▸ EML4 Q9HC35 3/20 0.34
▸ ALK Q9UM73 3/20 0.34
▸ PDE4B Q07343 1/20 0.34
▸ AXL P30530 2/20 0.34
▸ ETV6 P41212 1/20 0.34
▸ PDGFRA P16234 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HRH3 Q9Y5N1 1/20 0.34
▸ CDK1 P06493 1/20 0.34
▸ KDR P35968 1/20 0.34
▸ BTK Q06187 1/20 0.34
▸ RET P07949 1/20 0.34
▸ ROS1 P08922 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL30205666 0.97 TBK1 (0.37) TBK1IKBKESYKCCNCCDK8
SCHEMBL24943840 0.94 IKBKE (0.46) TBK1IKBKESYKMELKEML4
SCHEMBL30205589 0.94 IKBKE (0.46) TBK1IKBKESYKMELKEML4
SCHEMBL30205579 0.93 SYK (0.44) SYKCCNCCDK8EML4ALK
SCHEMBL24944183 0.93 SYK (0.44) SYKCCNCCDK8EML4ALK
Formic Acid SCHEMBL30206367 0.92 IKBKE (0.43) TBK1IKBKESYKMELKEML4
SCHEMBL24944446 0.90 EML4 (0.36) TBK1IKBKESYKEML4ALK
SCHEMBL24944169 0.90 EML4 (0.36) TBK1IKBKESYKEML4ALK
SCHEMBL24944443 0.90 EML4 (0.36) TBK1IKBKESYKEML4ALK
SCHEMBL24944456 0.89 IKBKE (0.38) TBK1IKBKESYKCCNCCDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117693503-A Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer 阿斯利康(瑞典)有限公司 2024-03-12 — — CN claimed
CN-117693503-A Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer 阿斯利康(瑞典)有限公司 2024-03-12 — — CN disclosed
WO-2023001794-A1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2023-01-26 — — WO disclosed
Send feedback